<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> and/or <z:hpo ids='HP_0000093'>proteinuria</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may stem from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal diseases</z:e> (CKD) other than classic diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in more than one-third of patients </plain></SENT>
<SENT sid="1" pm="."><plain>We interrogated urine proteomic profiles generated by surface-enhanced laser desorption/ionization-time of flight/mass spectrometry with the aim of isolating a set of biomarkers able to reliably identify biopsy-proven diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and to establish a stringent correlation with the different patterns of renal injury </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Ten micrograms of urine proteins from 190 subjects (20 healthy subjects, 20 normoalbuminuric, and 18 microalbuminuric diabetic patients and 132 patients with biopsy-proven <z:hpo ids='HP_0000112'>nephropathy</z:hpo>: 65 diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, 10 diabetic with nondiabetic CKD [nd-CKD], and 57 nondiabetic with CKD) were run using a CM10 ProteinChip array and analyzed by supervised learning methods (Classification and Regression Tree analysis) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The classification model correctly identified 75% of patients with normoalbuminuria, 87.5% of those with <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, and 87.5% of those with diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> when applied to a blinded testing set </plain></SENT>
<SENT sid="4" pm="."><plain>Most importantly, it was able to reliably differentiate diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> from nd-CKD in both diabetic and nondiabetic patients </plain></SENT>
<SENT sid="5" pm="."><plain>Among the best predictors of the classification model, we identified and validated two proteins, ubiquitin and Î²2-microglobulin </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Our data suggest the presence of a specific urine proteomic signature able to reliably identify type 2 diabetic patients with diabetic <z:hpo ids='HP_0000096'>glomerulosclerosis</z:hpo> </plain></SENT>
</text></document>